Customer Projects Improve Lila Platform

This is the core reason Lila can justify heavy lab capex early, because customer work is not just service revenue, it is also data acquisition for the model. Every Catalyst project and Creation campaign pushes more real experiments through Lila Iris and the AI Science Factory, producing structured results that can train the next version of the system. That makes a paid program look less like a one off CRO contract and more like a partially customer funded model improvement loop.1

• The practical difference from a CRO is what happens after a project ends. A CRO delivers assay results to the client, but Lila keeps the workflow knowledge from hypothesis generation, protocol choice, instrument control, and outcome data, then uses it to improve the next campaign across therapeutics, materials, and chemicals.1
• This same pattern shows up in other closed loop AI science companies, but with narrower scope. Isomorphic uses partner programs and internal drug work to improve a drug design engine, while Xaira uses internal programs to accumulate intervention outcome data. Lila is broader because it is trying to learn across multiple scientific domains, not just drug discovery.1 2 3
• Owning the physical execution layer matters because the best training data comes from experiments run in a consistent environment. Discovery Loop shows the opposite constraint. It can automate research logic in software, but expansion into biology and materials gets harder without standardized labs and proprietary experimental data.1 4

If this works, Lila can move from selling lab access to selling a progressively smarter discovery engine that gets better with every commercial program. The more utilization it drives through its factories, the more it can compound model quality, widen the gap with software only rivals, and support higher value pricing tied to outcomes instead of hours or instrument time.1 4